After reaching a tentative truce agreement with the striking workers, General Motors (NYSE: GM) is preparing to report third-quarter results on October
General Motors (GM) Q3 earnings preview: What changed since last report
Categories
Analysis
Walgreens Boots (WBA) earnings preview: No surprises expected in Q4 report
It has been a tough year for Walgreens Boots Alliance (NASDAQ: WBA) so far, with the stock losing steadily amid muted sales
AT&T (T) earnings preview: Q3 results to be influenced by these factors
AT&T (NYSE: T) will be reporting its third-quarter results on Monday before the opening bell, days after the communications firm faced severe
Amazon (AMZN) Q3 earnings preview: Key factors to watch for
Amazon (NASDAQ: AMZN) disappointed the market when it released second-quarter results a few months ago, with a surprise earnings miss that triggered
Will wireless prowess help Xilinx (XLNX) overcome China issues in Q2?
Xilinx (NASDAQ: XLNX) disappointed the market a few months ago when it issued below-consensus guidance for the September-quarter and the stock suffered
PayPal (PYPL) Q3 earnings preview: Investments, volume to influence results
After recording double-digit earnings and revenue growth in the second quarter, PayPal Holdings (NASDAQ: PYPL) lowered its full-year revenue guidance in July,
Biogen (BIIB) earnings preview: Will stock bounce back after Q3 report?
The market value of pharma giant Biogen, Inc. (NASDAQ: BIIB) declined by a third in March when the stock suffered a heavy
Understanding the pros and cons of investing in Alibaba (BABA) stock
Rarely do market watchers recommend a stock so overwhelmingly as they have done in the case of Chinese e-commerce firm Alibaba (NYSE:
Why is AMD a better investment option after de-escalation of tariff war?
After ending the downtrend that lasted for several weeks, shares of Advanced Micro Devices (NASDAQ: AMD) finally bounced back a few days
Can Intuitive Surgical (ISRG) thrive on the health of da Vinci system in Q3?
Intuitive Surgical (NASDAQ: ISRG), a market leader in robotic-assisted surgical systems, continues to scale new heights aided by the success of its
A bleak Q3 awaits Bank of America (BAC) amid low interest rates, trade dispute
The general mood is not very encouraging ahead of the earnings season for banks, which is about to start, and the primary
Twitter steers downward on weak revenue growth rate
Twitter Inc. (NYSE: TWTR) stock has fallen over 13% in the past month despite rising over 38% in the year so far.
Retailers take strong stand against guns and e-cigs; stocks remain steady
Two of the biggest controversies in recent times have been with regards to guns and e-cigarettes. Several deaths have been caused by
Nio deliveries finally improve, but will this help outplay Tesla?
Nio Inc. (NYSE: NIO) stock continued its gains on Tuesday as the ramp-up of its premium electric SUV, ES6, drove deliveries higher
SmileDirectClub stock hits its lowest since IPO amid analyst initiations
SmileDirectClub (NASDAQ: SDC) stock has fallen 32% to $11.20 on Tuesday, which is the teledentistry company's lowest since the initial public offering
PepsiCo: How the snack business steered the company away from rough waters
PepsiCo Inc. (NYSE: PEP) is a leader in its industry and the company has delivered healthy results consistently. This growth has mostly
General Motors: A look at deliveries over the past year
General Motors (NYSE: GM) is in the midst of a dispute with labor unions that has now entered its fourth week with
Softbank’s hopes are now pinned on this rapid-growth “WeWork-like” unicorn
It’s been a pretty rough year so far for Japanese conglomerate Softbank, which invests primarily in technology firms around the globe. It’s
Can beer companies expect new fizz from their cannabis ventures?
The beer business is an area that usually remains unaffected by the general ups and downs of the market as people normally
Kroger might need to do more than cost-cutting to bounce back
After registering record e-commerce sales last year, grocery store chain Kroger (NYSE: KR) has been on a mission to transform itself into
Strong pipeline and innovation make Novartis a sure bet, despite setbacks
The uncertainties surrounding drug development and intense competition are the primary challenges facing pharmaceutical companies, which also prompt investors to approach the